We are going to take #Nanopore sequencing into the clinical laboratory. Come and find out what we’re working on at #NSCMID2023. Rumour has it, the Nordic labs are leading the way.

There is definite a place for Metagenomics in diagnostics of infectious diseases now , especially for Nanopore sequencing, according to David Eyre at #NSCMID2023

Straight from his talk on the showcase stage, Manop Pithukpakorn shared how #nanopore sequencing has the potential to address the gaps in current clinical testing — from resolving missing CNVs to identifying complex structural variants. #nanoporeconf

"Death by tuberculosis is caused by human built systems" Such a strong speech by 🐢🐢🐢John Green🐢🐢🐢 👏👏👏

Uladzimir Antonenka presenting his work on Oxford Nanopore targeted sequencing of TB achieving 90% sensitivity across the board with including the new BPAL regime.

Wow! 2023 has been incredible for BugSeq and our customers. We're thrilled to highlight some of our favorite uses of BugSeq over the past year with a new blog post: docs.bugseq.com/blog/2023/12/2…

thepathologist.com/diagnostics/br…

Stop by Grande Suite 2029 in Tower II to meet our P2 solo and P2 integrated devices. We’re also demoing EPI2ME analysis #AGBT #AGBT24

Introducing NO-MISS. An end-to-end method for rapid, comprehensive isolate sequencing. Flexible sample batching & cost efficiency make it ideal for detecting outbreaks, understanding microbial evolution, food safety, & clinical research. Learn more: bit.ly/3x5mglr

Sample to answer. 🧫 ➡️ 📋 Oxford Nanopore #EPI2ME easy to use local analysis with wf-bacterial-genomes: ⭐️Assembly ⭐️Annotation ⭐️MLST ⭐️AMR ⭐️Bug specific analysis MLST derived identity allows bespoke downstream modules like Salmonella serotyping with SeqSero2. #WYMM

Natalia and I will be at #ECCMID2024 on the Oxford Nanopore booth - we'll be doing a data for breakfast on the #EPI2ME platform and the demos throughout the conference of AmPORE-TB, isolate sequencing (NO-MISS) and metagenomics/barcoding. Be sure to stop by and say hello!

So excited to announce our partnership with BugSeq! #InfectiousDisease #ECCMID 🦠 Neil Doherty Aaron Pomerantz, PhD Oxford Nanopore

Now that’s what I call a packed house! Thank you #ESCMID community and our fantastic speakers for an exciting symposium on Oxford Nanopore sequencing applied to long-read 16S, tuberculosis drug resistance, nanopore-only bacterial genome wgMLST, and the future of metagenomics

Would you like to use Adative sampling but dont know where to start? Or, do you have THE set of coordinates you think that everyone should use? If either of these are yes, please feel free to browse the open apdative science catalogue. Oxford Nanopore community.nanoporetech.com/adaptive_sampl…

Our latest paper evaluating Oxford Nanopore R10.4.1 sequencing for de novo assembly of bacterial pathogen genomes has been published in Microbiology Society. We may no longer need hybrid assemblies microbiologyresearch.org/content/journa…

Today we kick off London Calling 2024 with the data analysis workshops and virtual masterclasses. Join thousands online and learn how to supercharge your genomics research with nanopore technology. Register now: bit.ly/4booFqE #nanoporeconf #WYMM

🦠 #Tuberculosis is on the rise! The future of #TB diagnostics is Oxford Nanopore amplicon sequencing. From 2 months culture and phenotypic drug susceptibility testing —> to 8 hours by #Ampore_TB #MDR #AMR #nanoporeconf #freezeTB (Dr S Buckwalter MayoClinic)

Moving forward to clinical service 🤩

Curious about sequencing #RNA directly including mod bases? Register to join me for this webinar (11 July) explaining how #directRNA seq works plus recent updates & how they might work for your research needs! I'll be available for Q&A afterwards too. Oxford Nanopore #mRNA Details⬇️

Slow turnaround times can hamper efforts to control disease outbreaks. Discover in our brochure how #nanopore sequencing empowers real-time data analysis, offering immediate insights to quickly guide public health actions. Learn more: bit.ly/4ftjuIa #WYMM